Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ: CSBR )

10.59 +0.81 (+8.28%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Champions Oncology, Inc. - Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
Via ACCESSWIRE
Recap: Champions Oncology Q2 Earnings
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million
Via ACCESSWIRE
Earnings Scheduled For December 11, 2024
Via Benzinga
A Peek at Champions Oncology's Future Earnings
Via Benzinga
A Preview Of Champions Oncology's Earnings
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $14.0 Million
Via ACCESSWIRE
Champions Oncology: Q3 Earnings Insights
Via Benzinga
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024
Via ACCESSWIRE
Champions Oncology Announces Agreement with Weill Cornell Medicine
Via ACCESSWIRE
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
Earnings Outlook For Champions Oncology
Via Benzinga
Recap: Champions Oncology Q2 Earnings
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
Via ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
Via ACCESSWIRE
CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024
CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
Via ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.0 Million
Via ACCESSWIRE
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
Via ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
Via ACCESSWIRE
Earnings Scheduled For March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. 
Via Benzinga
Insiders Buying Solid Biosciences And 2 Other Stocks
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades. 
Via Benzinga
Insiders Buying Tilly's And 2 Other Stocks
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. 
Via Benzinga
Why Is RiskOn International (ROI) Stock Up 28% Today?
RiskOn International stock is rising higher on Wednesday as investors react to insider buying of ROI shares by Milton C. Ault III. 
Via InvestorPlace
CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024
CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.